Search for: "Eli, Inc."
Results 181 - 200
of 1,001
Sort by Relevance
|
Sort by Date
16 Feb 2018, 12:00 am
In Apple Inc., 2017 BL 452782 (Dec. 15, 2017), Apple Inc. [read post]
31 Jan 2018, 10:05 pm
Article 3(a): a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
29 Jan 2018, 2:57 am
The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
23 Jan 2018, 7:29 pm
Cir. 2015) (citing Eli Lilly & Co. v. [read post]
19 Dec 2017, 2:40 pm
TevaParenteral Medicines, Inc., 845 F.3d 1357 (Fed. [read post]
7 Dec 2017, 9:34 pm
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
The Plaintiffs, Eli Lilly and Company, Eli Lilly Export S.A., and Acrux DDS Pty Ltd. had filed a patent infringement lawsuit in the Southern District of Indiana alleging that Defendants, Perrigo Company, Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and… [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
1 Dec 2017, 6:20 am
The Swiss Federal Patent court had originally denied the infringement of Eli Lilly's patent but the Supreme Court granted Eli Lilly, a remarkable event in itself. [read post]
16 Nov 2017, 9:30 pm
Bush Administration and has worked for the drug company Eli Lilly. [read post]
9 Nov 2017, 9:04 am
Eric Sutton is a senior patent counsel at Oracle and an adjunct professor at Chicago-Kent College of Law. [read post]
6 Nov 2017, 5:34 am
(in Royson) Nugget Casino, Owens Corning Fiberglas, Sierra Pacific Power Company, Southern Pacific Company, Wells Cargo Inc. [read post]
25 Oct 2017, 6:55 am
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
17 Oct 2017, 6:09 pm
Judge Robinson had concluded that the patent was valid, and applied the test articulated in eBay Inc. v. [read post]
6 Oct 2017, 2:34 pm
Gen-Probe Inc., 323 F.3d 956 (Fed. [read post]
6 Oct 2017, 2:34 pm
Gen-Probe Inc., 323 F.3d 956 (Fed. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
23 Sep 2017, 12:39 pm
Cir. 2015); Eli Lilly, 845 F.3d at 1370. [read post]
12 Sep 2017, 4:00 am
The doctrine of collateral estoppel has two requirements: (1) “the identical issue necessarily must have been decided in the prior action and be decisive of the present action,” and (2) “the party to be precluded from relitigating the issue must have had a full and fair opportunity to contest the prior determination” (Kaufman v Eli Lilly & Co., 65 NY2d 449, 455 [1985]; see Ackman v Haberer, 111 AD3d 1378, 1379 [2013]). [read post]
